| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |